Smith D, Martinelli R, Besra G, Illarionov P, Szatmari I, Brazda P, et al. Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties. Psychopharmacology (Berl). 2019;: pubmed publisher

Lee W, Ham S, Lee G, Choi M, Yoo H, Paek K, et al. Activation of peroxisome proliferator-activated receptor delta suppresses BACE1 expression by up-regulating SOCS1 in a JAK2/STAT1-dependent manner. J Neurochem. 2019;151:370-385 pubmed publisher

Halstead A, Kapadia C, Bolzenius J, Chu C, Schriefer A, Wartman L, et al. Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation. elife. 2017;6: pubmed publisher

Wang B, Fu X, Zhu M, Du M. Retinoic acid inhibits white adipogenesis by disrupting GADD45A-mediated Zfp423 DNA demethylation. J Mol Cell Biol. 2017;9:338-349 pubmed publisher

Qian G, Fan W, Ahlemeyer B, Karnati S, Baumgart Vogt E. Peroxisomes in Different Skeletal Cell Types during Intramembranous and Endochondral Ossification and Their Regulation during Osteoblast Differentiation by Distinct Peroxisome Proliferator-Activated Receptors. PLoS ONE. 2015;10:e0143439 pubmed publisher

Niu H, Ku P, Niu C, Cheng J, Lee K. Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals. Drug Des Devel Ther. 2015;9:5625-32 pubmed publisher

Lin C, Tsai J, Chang C, Cheng J, Lin J. Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats. Drug Des Devel Ther. 2015;9:4709-17 pubmed publisher

Savage S, McCollum G, Yang R, Penn J. RNA-seq identifies a role for the PPARβ/δ inverse agonist GSK0660 in the regulation of TNFα-induced cytokine signaling in retinal endothelial cells. Mol Vis. 2015;21:568-76 pubmed

Chen T, Shih C, Hsu W, Chou T. Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets. PLoS ONE. 2015;10:e0127054 pubmed publisher

Fang X, Fang L, Liu A, Wang X, Zhao B, Wang N. Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells. Br J Pharmacol. 2015;172:3728-36 pubmed publisher

Suarez S, McCollum G, Bretz C, Yang R, Capozzi M, Penn J. Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ. Invest Ophthalmol Vis Sci. 2014;55:8232-40 pubmed publisher

Kim Y, Park K, Kim J, Seo H, Shin K, Lee Y, et al. An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production. Mol Cell Biol. 2014;34:4368-78 pubmed publisher

Sharif O, Gawish R, Warszawska J, Martins R, Lakovits K, Hladik A, et al. The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia. PLoS Pathog. 2014;10:e1004167 pubmed publisher

Tsai C, Lee K, Chen S, Chen L, Liu K, Cheng J. Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury. PPAR Res. 2014;2014:456386 pubmed publisher

Tsai C, Chan P, Chen L, Chang C, Liu Z, Lin J. Merit of ginseng in the treatment of heart failure in type 1-like diabetic rats. Biomed Res Int. 2014;2014:484161 pubmed publisher

Shih C, Lin I, Ding J, Chen F, Chou T. Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity. Br J Pharmacol. 2014;171:1490-1500 pubmed publisher

Capozzi M, McCollum G, Savage S, Penn J. Peroxisome proliferator-activated receptor-?/? regulates angiogenic cell behaviors and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2013;54:4197-207 pubmed publisher

Castillero E, Alamdari N, Aversa Z, Gurav A, Hasselgren P. PPAR?/? regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting. PLoS ONE. 2013;8:e59726 pubmed publisher

Ramachandran L, Manu K, Shanmugam M, Li F, Siveen K, Vali S, et al. Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor ? activation pathway in gastric cancer. J Biol Chem. 2012;287:38028-40 pubmed publisher

Mottillo E, Bloch A, Leff T, Granneman J. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) α and δ in brown adipocytes to match fatty acid oxidation with supply. J Biol Chem. 2012;287:25038-48 pubmed publisher